Menu
We connect science, strategy, and execution across the pharmaceutical lifecycle.
We design and deliver methodologically rigorous evidence generation programmes, including clinical study design, systematic reviews, and real-world evidence.
We support the full publication process, from protocol development to peer-reviewed manuscripts and congress presentations.
We assess therapeutic assets across the full translational pathway, from preclinical evidence to clinical and real-world relevance, supporting licensing, acquisition, and investment decisions.
Our work integrates mechanism of action, clinical outcomes, and real-world context to identify clinically meaningful signals, target populations, and opportunities for differentiation. This includes the application of biomarker-driven approaches and patient stratification strategies to support precision medicine.
We ensure that strategy translates into real-world adoption by supporting product launches, stakeholder alignment, and market penetration.
Our work focuses on translating scientific and clinical strategy into actionable plans, engaging key stakeholders, and enabling effective execution in real-world settings.
We support strategic decision-making across portfolios, including prioritisation of assets, lifecycle planning, and go/no-go decisions.
By integrating scientific, clinical, and real-world evidence, we help clients focus resources on the opportunities with the highest potential for clinical and commercial impact.
We support the definition of regulatory pathways and evidence strategies to enable approval and access across global markets.
Our experience includes complex environments such as Brazil and Latin America, where we combine global standards with local insight to support efficient and effective market entry.
We design and implement partnerships that connect academia and industry, supporting research strategies, talent development, and innovation.
Our work helps translate scientific discovery into development opportunities and real-world application.
We welcome conversations on how to translate scientific insights into strategic and real-world impact
Mauricio Silva de Lima, M.D., Ph.D.
Founder & Director, Translational Strategy
📧 Email: msdlima@pulsuspharma.com
đź“ŤLocation: based in the United Kingdom, with international reach
Initial discussions are confidential and without obligation
